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Abstract 
The present study tested the hypothesis that the Dahl SS (salt-sensitive) rat has vascular dysfunction 
due, in part, to the up-regulation of the CYP4A/20-HETE (cytochrome P450 ω-hydroxylase 4A)/20-
hydroxyeicosatetraenoic acid) system. To assess the role of vascular 20-HETE, SS rats were compared 
with SS-5BN consomic rats, carrying CYP4A alleles on chromosome 5 from the normotensive BN (Brown 
Norway) introgressed on to the SS genetic background. Cerebral arteries from SS-5BN rats had less CYP4A 
protein than arteries from SS rats fed either NS (normal-salt, 0.4% NaCl) or HS (high-salt, 4.0% NaCl) diet. 
ACh (acetylcholine)-induced dilation of MCAs (middle cerebral arteries) from SS and SS-5BN rats was 
present in SS-5BN rats fed on either an NS or HS diet, but absent in SS rats. In SS rats fed on either diet, 
ACh-induced dilation was restored by acute treatment with the CYP4A inhibitor DDMS (N-methyl-
sulfonyl-12,12-dibromododec-11-enamide) or the 20-HETE antagonist 20-HEDE [20-hydroxyeicosa-
6(Z),15(Z)-dienoic acid]. The restored response to ACh in DDMS-treated SS rats was inhibited by L-NAME 
(NGnitro-L-arginine methyl ester) and unaffected by indomethacin or MS-PPOH [N-methylsulfonyl-6-(2-
propargyloxyphenyl)hexanamide]. Vascular relaxation responses to the NO donor C5FeN6Na2O were 
intact in both SS and SS-5BN rats and unaffected by the acute addition of DDMS, indicating that the 
vascular dysfunction of the SS rat is due to a reduced bioavailability of NO instead of failure of the 
VSMCs (vascular smooth muscle cells) to respond to the vasodilator. Superoxide levels in cerebral 
arteries of SS-5BN rats [evaluated semi-quantitatively by DHE (dihydroethidium) fluorescence] were 
lower than those in the arteries of SS rats. These findings indicate that SS rats have an up-regulation of 
the CYP4A/20-HETE pathway resulting in elevated ROS (reactive oxygen species) and reduced NO 
bioavailability causing vascular dysfunction. 
CLINICAL PERSPECTIVES • Recent studies have reported an association between increased urinary 20-HETE excretion, 
endothelial dysfunction and elevated blood pressure in humans. • The present study used Dahl SS (salt-sensitive) rats, a genetic rodent model of salt-sensitive 
hypertension in humans, and a unique consomic rat strain carrying CYP4A alleles from the salt-
insensitive Brown Norway rat to investigate the role of 20-HETE in contributing to vascular 
dysfunction in salt-sensitive hypertension. The experiments revealed a direct relationship between 
20-HETE and vascular dysfunction in the Dahl SS rat. • Owing to the intimate relationship between vascular function and cardiovascular health, the present 
findings could provide important clues to increase our understanding of the role of the CYP4A/20-
HETE system in contributing to the changes in vascular function occurring in human hypertension 
and/or salt-sensitive subjects. 
INTRODUCTION 
Endothelial dysfunction is the failure of the endothelial cell layer to maintain vascular homoeostasis, 
resulting in increasing vascular constriction and reduced vascular relaxation to vasodilator stimuli. 
Increased levels of ROS (reactive oxygen species) in the endothelium not only compromise NO (nitric 
oxide)-dependent vasodilatation, but also overwhelm the antioxidant, anti-inflammatory and anti-
proliferative properties of NO in the vessel wall. Endothelial dysfunction is associated with hypertension 
[1,2] and many other CVDs (cardiovascular diseases) [3] and has been shown to be an early prognosticator 
of future adverse cardiovascular-related incidents (including myocardial infarction, stroke and death) 
[3,4]. 
20-HETE (20-hydroxyeicosatetraenoic acid) is a vasoconstrictor metabolite of arachidonic acid formed in 
VSMCs (vascular smooth muscle cells) through the action of CYP4A (cytochrome P450 ω-hydroxylase 
4A). The CYP4A/20-HETE system has been implicated in the development of hypertension in humans 
and animals [5–8]. Studies on human subjects have shown an association between genetic variants in 
CYP4AF, a human gene that forms 20-HETE, and an increase in both urinary excretion of 20-HETE and 
MAP (mean arterial pressure) [5,6]. In animal models, SHR (spontaneously hypertensive rats) [7] and 
androgen-induced hypertensive rats [9] have elevated vascular 20-HETE and high BP (blood pressure) 
that can be ameliorated with a CYP4A inhibitor. Cyp4a14 knockout mice further demonstrate the role of 
the CYP4A/20-HETE pathway in the development of hypertension as these mice develop severe 
hypertension as a result of increased expression of the Cyp4a12 isoform in the kidney and enhanced 20-
HETE production [8]. 
In addition to the pro-hypertensive effects of 20-HETE, the CYP4A/20-HETE pathway has also been 
associated with endothelial dysfunction. Ward et al. [10] demonstrated an association between elevated 
urinary 20-HETE excretion and endothelial dysfunction in humans. Similar to reports in hypertensive rat 
models [7,9], S–D (Sprague–Dawley) rats receiving a CYP4A2-carrying adenovirus demonstrate increased 
BP, reduced ACh (acetylcholine)-induced vascular relaxation and attenuated NO production [11]. In Dahl 
SS (salt-sensitive) rats, the constriction of skeletal muscle arterioles in response to elevated PO2 (partial 
pressure of O2) is potentiated by increased dietary salt, an effect that can be abolished with 20-HETE 
inhibition [12]. 
The present study tested the hypothesis that an up-regulation of the CYP4A/20-HETE system plays a 
direct role in vascular dysfunction of the SS rat through the production of ROS and the subsequent 
decrease in NO bioavailability. Earlier studies showed that a 3-day HS (high-salt) diet causes an up-
regulation of CYP4A mRNA in SS cremasteric arterioles [12], and in mesenteric arteries from S–D rats [13], 
suggesting an association between increased dietary salt and elevated 20-HETE production in resistance 
arteries. Although it is clear that salt can activate the CYP4A/20-HETE pathway, SS rats also exhibit 
vascular dysfunction when they are normotensive and maintained on an NS (normal salt) diet. As such, 
increases in the CYP4A/20-HETE system may be independent of dietary sodium [14–16]. In order to 
determine the direct effects of salt on the CYP4A/20-HETE pathway independent of changes in arterial 
pressure, the present study evaluated the effect of short-term (3 days) elevated dietary salt intake, as 
the Dahl SS rat does not demonstrate salt-induced pressure changes within this limited time frame [16]. 
In addition, we evaluated vascular function in a novel consomic rat strain (SS-5BN) carrying CYP4A alleles 
from the BN (Brown Norway) rat in the Dahl SS genetic background that exhibits dramatic attenuation of 
salt-sensitivity of BP [17]. 
The SS-5BN rat is a strain developed by the PGA (Program for Genomic Applications) group at the MCW 
(Medical College of Wisconsin) as part of a consomic panel of rats in which single chromosomes from 
the BN rat were introgressed individually on to the genetic background of the Dahl SS rat using marker-
assisted selection [18]. As reported by Cowley et al. [18], consomic rat strains allow investigation into the 
role of specific genes and chromosomes in controlling physiological traits with reduced genetic 
variability. For this reason, the SS-5BN consomic rat, carrying CYP4A genes on chromosome 5 from the 
BN rat, is an excellent control animal for the investigation of the role of CYP4A and 20-HETE in vascular 
dysfunction in the Dahl SS rat. Specifically, the SS-5BN consomic rat has ~95% genetic homology with the 
Dahl SS rat, but exhibits protection from salt-induced BP elevations [17]. We hypothesized that these rats 
would also have protection from the vascular dysfunction present in the SS rat due to a decreased 
contribution of the CYP4A/20-HETE pathway. 
MATERIALS AND METHODS 
Experimental groups 
Male SS (SS/JrHsd/Mcwi) and SS-Chr 5BN/Mcwi (SS-5BN) rats 8–10 weeks old were fed on either NS (0.4% 
NaCl; Dyets) from weaning or switched to an HS diet (4.0% NaCl; Dyets) for 3 days prior to the 
experiments, with water ad libitum. The MCW Institutional Animal Care and Use Committee approved 
all the protocols. 
Isolated vessel experiments 
The animals were anaesthetized with intramuscular injection containing (in mg/kg of body weight): 
ketamine (75.0), acepromazine (2.5) and anased (10.0). MCAs (middle cerebral arteries) were 
cannulated as described previously [19] and internal diameter was measured using television microscopy. 
Vessels lacking active tone at rest were excluded from the study. 
Responses to ACh (10−10–10−5 mol/l) and C5FeN6Na2O (10−12–10−4 mol/l) were determined before and 
after the treatment with DDMS (N-methylsulfonyl-12,12-dibromododec-11-enamide, 50 μmol/l) or 20-
HEDE [20-hydroxyeicosa-6(Z),15(Z)-dienoic acid, 1 μmol/l]. In another experiment, responses to ACh 
before and after incubation with L-NAME (NG-nitro-L-arginine methyl ester; 100 μmol/l) to inhibit NOS, 
indomethacin (1 μmol/l) to inhibit cyclo-oxygenase, or MS-PPOH [N-methylsulfonyl-6-(2-
propargyloxyphenyl)hexanamide; 100 mmol/l] to inhibit epoxygenases were recorded in DDMS-treated 
MCA from SS rats and control MCA from SS-5BN rats. Additional vessels were incubated without 
inhibitors as a time control. 
At the end of the experiment, the maximum diameter was determined by adding H2O2 (1.76 mmol/l) to 
the superfusate to achieve maximum dilation. Active resting tone (%) was calculated as 
[(Dmax−Drest)/Dmax]×100, where Dmax is the maximum diameter in the presence of H2O2 and Drest is the 
resting control diameter. 
Western blotting 
CYP4A protein expression in cerebral arteries was assessed by Western blotting as described previously 
[13,20,21] using the CYP4A1/A2/A3 antibody (sc-53247; Santa Cruz Biotechnology). Expression of eNOS 
(endothelial nitric oxide synthase) (610296; BD Biosciences), peNOS (phospho-eNOS) (612393;BD 
Biosciences), Cu/Zn-SOD (copper/zinc superoxide dismutase) (Enzo Life Sciences), Mn-SOD (manganese 
SOD) (Assay Designs) and EC-SOD (extracellular SOD) (sc-3222; Santa Cruz Biotechnology) were also 
assessed using Western blotting. Relative intensity of the bands was quantified and normalized to a 
loading control (β-actin) using a computer-based densitometer system and Image-Quant software 
(Molecular Dynamics). 
DHE (dihydroethidium) fluorescence 
Vascular ROS levels in basilar arteries were assessed semi-quantitatively using DHE [22]. Basilar arteries 
were used as a substitute for MCA, as both vessels demonstrate an NO-dependent dilation to ACh [23], 
and the larger diameter allows for improved cross-sectioning. In these experiments, the arteries were 
isolated and incubated for 1 h in PSS heated to 37° with DHE (5 μmol/l) for the final 15 min. The vessels 
were cut into 10 μm transverse sections and imaged with a Nikon Eclipse TS100 microscope equipped 
with a ×20 objective, a 540-nm excitation filter, a 605-nm emission filter (Chroma Technology) and 
QImaging Regiga-2000R digital camera. Fluorescence of multiple images of each artery was quantified 
using ImageJ software and background fluorescence was subtracted from the fluorescence value of the 
basilar artery ring [22]. 
Statistical analysis 
Data are summarized as means±S.E.M. For comparisons of two groups, an unpaired Student's ttest was 
used. For all concentration–response curves, differences between multiple groups at each concentration 
were determined using a one-way ANOVA. Differences between individual means following ANOVA 
were evaluated using a post-hoc Student–Newman–Keuls test. A probability level of P<0.05 was 
considered to be statistically significant. 
RESULTS 
Arterial BP and vessel characteristics 
The PGA at the MCW generated SS-5BN rats and performed phenotyping protocols, including assessment 
of conscious BP in the parental and consomic strains. SS-5BN consomic rats are protected from salt-
induced increases in MAP (130±2.6 mmHg) following a 3-week HS (8.0% NaCl) diet compared with the SS 
rat (177±2.5 mmHg). The present study utilized a 3-day HS diet of 4.0% NaCl because SS rats remain 
normotensive within this time frame [16,24] and thus BP differences between the two rat strains should 
not affect our results. Active resting tone (Table 1) was unaffected by the HS diet or any of the inhibitors 
in either strain; the only exception being HS-fed MCA of SS rats treated with 20-HEDE; which may be due 
to an increased contribution of 20-HETE in SS rats fed on an HS diet. Nonetheless, the consistency of 
active resting tone between treatment groups indicates changes in the magnitude of vascular relaxation 
in different experimental groups are independent of differences in resting tone and do not reflect a pre-
existing constriction. 
Table 1 MCA diameters and resting tone 
Values are means±S.E.M. *P<0.05, significantly different from NS- and HS-fed SS rats in all categories, 
except NS-fed SS rats without inhibitor; †P<0.05, significantly different from NS- and HS-fed SS rats in 
the presence of either MS-PPOH or 20-HEDE; ‡P<0.05, significantly different from every other treatment 
group in the same category. INDO, indomethacin. 
Experimental group Number (n) Maximum diameter 
(μm) 
Resting diameter 
(μm) 
Active tone 
(%) 
SS NS 8 256±2.9† 129±11.3 50±4.0 
SS HS 8 248±5.2 152±5.0 40±2.4 
SS NS+DDMS 8 240±1.8 145±8.0 39±3.2 
SS HS+DDMS 8 238±2.4 135±5.6 43±2.1 
SS NS+20-HEDE 6 236±4.2 145±9.3 39±1.9 
SS HS+20-HEDE 6 232±1.9 175±6.7‡ 25±1.3‡ 
SS NS+DDMS+L-NAME 8 240±1.8 140±6.7 42±2.7 
SS HS+DDMS+L-NAME 8 238±2.4 133±6.8 44±2.6 
SS NS+DDMS+INDO 6 240±1.9 143±3.5 40±1.1 
SS HS+DDMS+INDO 6 237±1.7 139±5.1 41±2.0 
SS NS+DDMS+MS-
PPOH 
6 233±2.4 130±1.9 44±1.0 
SS HS+DDMS+MS-
PPOH 
6 233±2.0 135±3.8 42±1.7 
SS-5BN NS 8 265±5.4* 140±6.6 47±2.5 
SS-5BN HS 8 260±7.2* 137±2.6 47±1.3 
SS-5BN NS+DDMS 8 265±5.4* 133±4.4 49±2.4 
SS-5BN HS+DDMS 8 260±7.2* 139±6.6 47±1.3 
SS-5BN NS+L-NAME 6 252±4.0 131±5.9 47±1.5 
SS-5BN HS+L-NAME 6 249±4.7 132±5.7 47±2.7 
SS-5BN NS+INDO 5 249±7.6 134±6.9 46±2.4 
SS-5BN HS+INDO 5 246±5.7 141±7.7 43±3.0 
 
Effect of CYP4A inhibition and 20-HETE antagonism on vascular relaxation 
MCAs from NS-fed (Figure 1A) or HS-fed (Figure 1B) SS rats failed to dilate in response to the 
endothelium-dependent vasodilator ACh. Vascular relaxation to ACh was restored by inhibiting 20-HETE 
production with DDMS in SS rats fed on either an NS or HS diet, and also by treatment with the 20-HETE 
antagonist 20-HEDE. 
 
Figure 1 Response to ACh in MCA of SS rats fed on an NS (A) or HS (B) diet with or without the acute addition of 
DDMS or 20-HEDE 
Data are expressed as the mean±S.E.M. change in diameter from baseline (μm) *P<0.05, significant difference 
from response in the absence of inhibitor, same diet. 
 
Mechanisms of restored vascular relaxation 
The responses of DDMS-treated MCA from SS rats (with or without the NOS inhibitor L-NAME, the cyclo-
oxygenase inhibitor indomethacin, or the epoxygenase inhibitor MS-PPOH) are shown in Figure 2. The 
restored dilation in response to ACh in DDMS-treated MCAs from SS rats fed on an NS (Figure 2A) or HS 
diet (Figure 2B) was eliminated by L-NAME, demonstrating an NO-dependent response. Vessel 
responses to ACh did not utilize either the cyclo-oxygenase or epoxygenase pathways, as their 
respective inhibitors did not affect the magnitude of vasodilation. 
 
Figure 2 Response to ACh in DDMS-treated MCA of SS rats fed on an NS (A) or HS (B) diet with or without the L-
NAME, indomethacin or MS-PPOH (n=8 for all groups) 
Data are expressed as the mean ±S.E.M. change in diameter from baseline (μm) *P<0.05, significant difference 
from L-NAME-treated arteries. 
 
Effect of BN CYP4A alleles on vascular relaxation 
Introgressing CYP4A genes from the BN rat into the SS genetic background restored vascular responses 
to ACh in SS-5BN rats fed on either an NS or HS diet; and this dilation was unaffected by DDMS (Figure 
3A). The ACh-induced response in these vessels was NO-dependent, as the response was blocked by L-
NAME and unaffected by indomethacin (Figure 3B). Time control experiments (results not shown) 
demonstrated no effect of the incubation period on vascular responses to ACh in any group. MCAs from 
both SS and SS-5BN rats fed on an NS and HS diet showed robust dilation to the NO donor C5FeN6Na2O, 
with no additional effect of DDMS (Figure 4), showing vascular dysfunction in the SS rat is not due to a 
failure of VSMCs to respond to NO. 
 
Figure 3 Response to ACh in MCA of SS-5BN rats fed on an NS or HS diet with or without acute addition of DDMS 
(A) or either L-NAME or indomethacin (B) 
Data are expressed as the mean ±S.E.M. change in diameter from baseline (μm) *P<0.05, significant difference 
from L-NAME-treated vessels. 
 
 
Figure 4 Response to C5FeN6Na2O (10−12–10−5 M) in isolated MCAs of Dahl SS rats (A) and SS-5BN consomic rats (B) 
fed on an NS or HS diet (n=12 in all groups) with or without the acute addition of DDMS (50 μM) to the perfusate 
and superfusate 
Data are expressed as the mean±S.E.M. change in diameter from baseline (μm) 
 
CYP4A enzyme expression in cerebral arteries from SS and SS-5BN rats 
CYP4A protein expression was significantly lower in cerebral arteries from SS-5BN rats compared with 
arteries from SS rats fed on either NS (Figure 5A) or HS (Figure 5B). CYP4A expression was unaffected by 
changes in dietary salt intake in either animal strain (Figures 5C and 5D). 
 
Figure 5 Western blots comparing CYP4A protein (50 kDa) expression in cerebral arteries from (A) NS-fed SS rats 
compared with SS-5BN rats, (B) HS-fed SS and SS-5BN rats (C) NS compared with HS in SS rats, and (D) NS 
compared with HS in SS-5BN rats (n=8 for all groups) 
Data are presented as a percentage of β-actin expression. *P<0.05, significant difference from cerebral vessels 
from SS, same diet. 
 
ROS levels, SOD expression and eNOS expression 
Consistent with the hypothesis that the vascular effects of 20-HETE are mediated via oxidative stress, 
ROS levels evaluated semi-quantitatively via DHE fluorescence were significantly higher in basilar 
arteries of SS rats compared with those of SS-5BN rats fed on the same diet. ROS levels in HS-fed SS rats 
were also significantly higher than those in SS rats fed on an NS diet (Figure 6). Western blotting 
revealed no difference in antioxidant protein expression (Mn-SOD, Cu/Zn-SOD and EC-SOD; Figures 
7A, 7B and 7C respectively) or in peNOS/eNOS expression (Figure 7D) in any of our treatment groups; 
suggesting vascular dysfunction in SS rats compared with SS-5BN rats is not due to alterations in 
antioxidant defences or in the activity of eNOS. 
 
Figure 6 Semi-quantitative evaluation of ROS levels via DHE fluorescence in basilar arteries from NS- and HS-fed 
SS and SS-5BN rats (n=6 for all groups) 
Upper panel, representative fluorescent and bright field images of basilar artery cross-sections (10 μm thickness) 
from SS and SS-5BN rats. Lower panel, vascular ROS levels expressed as fluorescence units in DHE-treated basilar 
artery cross-sections. Data are expressed as the mean±S.E.M. percentage of raw fluorescence units in NS-fed SS 
arteries. *P<0.05, significant difference from control NS-fed SS rats. 
 
 
Figure 7 Western blot analysis of protein expression of (A) Cu, Zn-SOD, (B) MnSOD, (C) EC-SOD and (D) eNOS and 
peNOS in cerebral vessels from Dahl SS and SS-5BN consomic rats fed on either an NS or HS diet 
Data are presented as a percentage of β-actin (A–C) or as a ratio of the percentage of β-actin of p-eNOS to the 
percentage of β-actin of eNOS (n=4 for all groups). 
 
DISCUSSION 
The present study shows that multiple interventions that interrupt the CYP4A/20-HETE pathway 
ameliorate the severe vascular dysfunction that exists in the cerebral arteries of Dahl SS rats fed on 
either a normal or an HS diet. Specifically, pharmacological interventions that either inhibit the catalytic 
function of CYP4A enzymes or antagonize the actions of 20-HETE both restored vascular relaxation in 
cerebral resistance arteries of Dahl SS rats. In a similar fashion, genetic substitution of chromosome 5 
carrying the CYP4A alleles from the BN rat on to the genetic background of the SS rat (the SS-
5BN consomic rat) reduced the influence of this pathway by decreasing vascular CYP4A protein 
expression, and this was accompanied by a restoration of endothelium-dependent vascular relaxation in 
response to ACh. One limitation of the present study is the inability of the current methodology, which 
assesses 20-HETE production under optimum conditions of PO2 and substrate availability, to evaluate 
differences in 20-HETE production under normal physiological conditions. As such, it is also conceivable 
that differences in CYP4A enzyme activity (in addition to differences in the expression of CYP4A enzymes 
in the arteries) may also exist in the two strains. Nonetheless, the findings of the current study suggest 
that up-regulation of the CYP4A/20-HETE pathway plays a direct role in the endothelial dysfunction that 
exists in the SS rat fed on an NS or HS diet. In this regard, the beneficial effects of chromosomal 
substitution and pharmacological interruption of the CYP4A/20-HETE pathway on vascular function in 
rats fed on an NS diet are especially important because they indicate that the CYP4A/20-HETE pathway 
may play an important role in contributing to vascular dysfunction in SS rats, even prior to the onset of 
hypertension. 
Previous studies have shown that increased levels of ROS are important contributors to vascular 
dysfunction in SS rats [22,25]. For example, cerebral vascular relaxation in response to ACh and 
reduced PO2 in SS rats fed on either an NS or HS diet can be restored by scavenging the superoxide with 
tempol [22,25]. In the present study, we utilized DHE fluorescence to evaluate vascular ROS levels. 
Although this approach has its limitations compared with other methods that provide a better 
quantitative evaluation of superoxide levels, for example HPLC determination of 2-hydroxyethidium, 
which is more feasible in other tissues [26–28], it still provides a valuable, albeit semi-quantitative, 
estimation of vascular ROS levels. In these experiments, we found that genetic manipulation of CYP4A 
protein expression via chromosome substitution in the SS-5BN consomic rat led to a decrease in vascular 
oxidant stress concomitant with a restoration of endothelium-dependent vasodilation to ACh in animals 
fed on either a normal or an HS diet. The latter findings suggest that impaired endothelial function in the 
SS rats and the beneficial effects of inhibiting 20-HETE production on vascular reactivity are secondary to 
a reduction in ROS. The latter interpretation is consistent with published findings showing that 20-HETE 
can increase vascular ROS via several mechanisms including: (i) the normal catalytic process of 20-HETE 
formation by CYP4A enzymes [29–31]; (ii) 20-HETE-induced NADPH oxidase activation [9,32–34]; and (iii), 
uncoupling of eNOS [35,36]. Since eNOS expression and phosphorylation of eNOS were similar in SS and 
SS-5BN rats and were unaffected by the HS diet, the most probably explanation for our findings is that 
reduced 20-HETE levels and/or CYP4A enzyme activity restore NO bioavailability by preventing the 
destruction of NO by superoxide anions, rather than via any effect on eNOS expression or activation. 
Current sequence analysis (http//www.rgd.mcw.edu) has identified a non-synonymous SNP (single 
nucleotide polymorphism) predicted to be damaging in the CYP4A8 allele of the SS rat that may affect 
expression of the other CYP4A isoforms. A similar phenomenon has been observed in the CYP4A14-
knockout mouse [8], in which the knockout of the CYP4A14 gene results in increased ω-hydroxylase 
activity [37], increased urinary excretion of 20-HETE and elevated MAP due to secondary up-regulation of 
the CYP4A12 gene [8,37]. This raises the possibility that one or more of the other CYP4A isoforms are up-
regulated in the Dahl SS rat due to a non-functional CYP4A8allele. This could provide a possible 
explanation for elevated CYP4A protein expression in cerebral arteries from Dahl SS rats fed on either a 
normal or an HS diet compared with arteries from SS-5BNconsomic rats, which do not carry the mutation. 
Multiple studies have shown that the Dahl SS rat is susceptible to heightened oxidative stress due to 
reduced antioxidant defence mechanisms, specifically in the myocardium [38], kidney [39,40] and 
vasculature [22]. In the present study, there were no differences in expression of any of the SOD enzymes 
between SS and SS-5BN rats fed on either diet. Owing to the pro-oxidant capabilities of 20-HETE, it is 
probable that the up-regulation of the CYP4A/20-HETE pathway operating in conjunction with reduced 
antioxidant defences in the SS genetic background leads to increased vascular oxidant stress in SS rats 
compared with SS-5BN consomic rats. We believe that the most probable reason for the restoration of 
endothelium-dependent vascular relaxation in SS-5BNconsomic rat is the reduced expression of CYP4A 
enzymes, resulting in lower levels of ROS that do not overpower antioxidant defence mechanisms that 
are compromised in the SS genetic background due, at least in part, to the chronically low AngII 
(angiotensin II) levels resulting from impaired regulation of the renin allele (found on chromosome 13) 
[22,25]. 
It is important to discuss the contrasting roles of 20-HETE in the pathogenesis of hypertension in the 
vasculature compared with the kidney, with specific reference to these two rat strains. In renal 
physiology, 20-HETE is generally considered to be anti-hypertensive due to its tubular effects promoting 
natriuresis [41,42]. Deficiencies in renal 20-HETE production have been associated with sodium retention 
and SS hypertension in both human [43] and animal studies [44–46]. In fact, Dahl SS rats have inadequate 
20-HETE production in the outer medulla [47], which can be ameliorated by introgressing BN 
chromosome 5 into the SS genetic background (the SS-5BN consomic rat) [48]. Those observations contrast 
with the increased expression of CYP4A enzyme protein in the vasculature that we observed in the 
present study. This is probably due to local differences in the regulation of CYP4A gene expression in the 
kidney and vasculature. For example, it has been shown that human hypertensive subjects have 
significantly higher amounts of plasma 20-HETE but a significantly lower urinary excretion of 20-HETE, an 
indirect indicator of renal 20-HETE production. Local control over 20-HETE synthesis may be a result of 
differences in the expression of certain receptors responsible for CYP4A enzyme activation within the 
kidney compared with the vasculature (e.g. receptors for either AngII or endothelin-1) [49] or due to local 
differences in signal transduction pathways. Regardless of these potential underlying mechanisms, our 
laboratory and others have consistently demonstrated that elevated 20-HETE production in the 
vasculature is deleterious and contributes to the development and progression of hypertension [11,13,50]. 
One very striking observation in the present study is that the HS diet failed to eliminate endothelium 
dependent dilation to ACh in arteries of the SS-5BN consomic rats. This finding is in contrast with the 
ability of the HS diet to eliminate endothelium-dependent dilation in arteries of salt-insensitive S–D rats 
[51], mice [52] and SS-13BN consomic rats carrying a normally functioning renin allele from the BN rat in the 
SS genetic background [24]. This raises the crucially important question of the relative role of the 
CYP4A/20-HETE pathway in contributing to salt-induced vascular impairment compared with cerebral 
vascular dysfunction independent of salt intake (e.g. in SS rats). Studies in mesenteric arteries of S–D 
rats have shown that an HS diet up-regulates CYP4A mRNA and protein expression, and that inhibiting 
CYP4A restores vascular relaxation response to reduced PO2 [13]. By contrast, the present study shows no 
difference in CYP4A protein expression in the MCA of SS rats fed on either an NS or HS diet; and 
pharmacological blockade of the CYP4A/20-HETE pathway with either DDMS or 20-HEDE restores 
vascular function in both NS- and HS-fed SS rats. The latter findings indicate that CYP4A enzymes 
contribute to overall vascular dysfunction in the SS rat, independent of dietary salt intake. This 
observation may have important significance in the light of previous studies [14,15,24,25] demonstrating that 
vascular relaxation mechanisms are lost in the MCA of SS, even when the animals are normotensive and 
maintained on an NS diet. 
One possible explanation for a role of the CYP4A/20-HETE pathway in vascular dysfunction independent 
of dietary salt in SS rats is a contribution of ROS to the regulation of CYP4A enzyme expression. A 
plausible mechanism by which ROS could exert a regulatory influence over the CYP4A/20-HETE pathway 
is indirect, via the effect of superoxide on NO. The superoxide anion reacts with NO at a rate three times 
higher than the interaction between superoxide and SOD, which has a major effect on the basal levels of 
NO [53]. NO inhibits CYP4A activity by forming a ferrous–nitrosyl complex at the haem-binding site of the 
CYP4A enzyme [54], and it has also been shown to decrease CYP4A protein expression [55,56]. In the 
present study, both CYP4A protein expression and ROS levels are increased in arteries from both NS- 
and HS-fed SS rats compared with the SS-5BN consomic rats. Previous studies indicate that elevated ROS 
levels in the arteries of Dahl SS rats reduce the bioavailability of NO within the vasculature [14,25]. As a 
result, the inhibitory influence of NO on the CYP4A/20-HETE pathway would be absent in arteries of 
Dahl SS rats, which could explain the up-regulation of the CYP4A/20-HETE pathway independent of 
dietary salt intake in Dahl SS rats. 
Consomic rat models provide an experimental animal with nearly identical genetic homology with the 
target animal (SS) while substituting genetic material from a normotensive rat strain (BN). However, 
there are still limitations to the conclusions that can be drawn from the data collected from these 
animals, as chromosome 5 carries BN alleles other than the CYP4A genes, which may contribute to the 
observed differences in the SS compared with the SS-5BN consomic rat in the present study. 
Nonetheless, the SS-5BN consomic rat is still an excellent animal model to test the present hypothesis 
that the CYP4A enzyme and 20-HETE contribute to vascular dysfunction in the SS rat, as they 
demonstrate a significant reduction in the salt-sensitivity of BP [17] and lack the vascular dysfunction 
observed in their close genetic counterpart, the SS rat. The improved vascular function observed in SS-
5BN mirrors the restored vasodilator responses in MCA from SS in the presence of the CYP4A inhibitor 
DDMS and the 20-HETE antagonist 20-HEDE. As noted above, cerebral arteries from SS-5BN also have a 
significantly lower expression of CYP4A protein, supporting the hypothesis that the restoration of 
endothelium-dependent vascular relaxation in cerebral arteries of the SS-5BN rats reflects a reduced 
contribution of the CYP4A/20-HETE system to vascular regulation. 
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